Clinical Trials Logo

Cardiac Surgery clinical trials

View clinical trials related to Cardiac Surgery.

Filter by:

NCT ID: NCT05353348 Recruiting - Cardiac Surgery Clinical Trials

Effect of the Combined Programme on Perioperative Anaemia(CPPA)

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

We used the preoperative intervention of iron sucrose in combination with human erythropoietin and vitamin C as an innovative combination therapy. This combined treatment strategy aims to improve perioperative anaemia in patients by promoting erythropoiesis and improving iron metabolism. Compared with previous perioperative intravenous iron supplementation, this innovative combination therapy strategy takes into account multiple aspects of iron metabolism as well as the biological mechanisms of erythropoiesis, providing a more comprehensive intervention. Management of perioperative anaemia in previous studies has largely relied on single intravenous iron supplementation therapy, and although this approach has been effective in raising iron levels, its effectiveness may be limited in patients who have impaired iron utilisation or in situations where concurrent stimulation of erythropoiesis is required. The use of iron sucrose in combination with human erythropoietin and vitamin C, on the other hand, is based on an integrative therapeutic concept aimed at providing a more comprehensive response to perioperative anaemia by simultaneously promoting effective iron utilisation and erythropoiesis.

NCT ID: NCT05345639 Not yet recruiting - Pain, Postoperative Clinical Trials

Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)

PABLOS
Start date: July 1, 2022
Phase: Phase 3
Study type: Interventional

The main objective is to compare the effectiveness of LocoRegional Anesthesia (LRA) (bilateral transverse thoracic block or bilateral parasternal block) in addition to standard management compared to standard management alone (general anesthesia without LRA) on the FQoR-15 (French Quality of Recovery - 15 score) at H+24 after cardiac surgery by sternotomy.This is a phase III monocentric superiority study , comparative, with three parallel groups, randomized with a ratio (1:1:1), controlled versus standard management, single-blind.

NCT ID: NCT05341037 Completed - Cardiac Surgery Clinical Trials

Red Cell Distribution With to Lymphocyte Ratio in Cardiac Surgery

Start date: June 15, 2022
Phase:
Study type: Observational

It is aimed to investigate whether red cell distribution with (RDW) to lymphocyte ratio (RLR) can predict early comorbidity among cardiac surgery patients.

NCT ID: NCT05321173 Completed - Cardiac Surgery Clinical Trials

Fast-Track in Cardiac Anesthesia

Start date: April 1, 2022
Phase:
Study type: Observational

The introduction of fast-track extubation procedures following cardiac surgery has significantly shortened hospitalization times in intensive care units. In this study, it was aimed to determine the obstacles to the early recovery of patients who underwent cardiac surgery in the crisis environment that developed with the pandemic.

NCT ID: NCT05308797 Completed - Postoperative Pain Clinical Trials

Combine Serratus Anterior Plane Block Versus Erector Spinae Plane Block in Coronary Bypass Surgery

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Even though Erector Spinae Plane (ESP) Block is shown to be efficient in cardiac surgery, the Combine Serratus Anterior Plane (CSAP) Block is still controversial if it has an efficient analgesic effect for sternotomy and drain tube pain relief. This study aims to compare ESP block and CSAP block for postoperative analgesia in coronary bypass surgery patients.

NCT ID: NCT05283590 Recruiting - Cardiac Surgery Clinical Trials

Automated Inferior Vena Cava Collapsibility Index Fluid Responsiveness in Ventilated Patients After Cardiac Surgery.

Start date: February 12, 2022
Phase:
Study type: Observational

Echocardiographic measurement of inferior vena cava (IVC) collapsibility index (CI) with automated software analyses has been introduced. This study aims to assess the accuracy of IVC-CI (caval index) measurements as well as the ability to track fluid responsiveness (FRes) over time comparing the automated echocardiographic method with the pulse pressure variation (PPV) technique and the manual echocardiographic method in cardiac surgery patients.

NCT ID: NCT05268562 Recruiting - Cardiac Surgery Clinical Trials

Ketamine and Kidney Injury in Cardiac Surgery

Start date: March 2, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.

NCT ID: NCT05225246 Completed - Cardiac Surgery Clinical Trials

Readmissions After Cardiac Surgical Procedures

Start date: September 1, 2020
Phase:
Study type: Observational

The aim of this study is to analyze the reasons for unplanned readmissions after cardiac surgery at the University Hospital Basel. Predictive factors for readmissions and the development over the last 10 years will be analyzed.

NCT ID: NCT05210335 Completed - Cardiac Surgery Clinical Trials

RISK ANALYSIS AND MANAGEMENT FOR MEDICATION OPTIMIZATION IN THE PREOPERATIVE AND POSTOPERATIVE PERIOD OF CARDIAC SURGICAL PATIENTS

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Optimal perioperative and long-term success in cardiac-surgery require precise management of drug treatment. This study was aimed to determine prevalence, types and associated factors of drug related problems (DRPs) at both preoperative and postoperative stages in patients at cardiac-surgery by using risk analysis method.

NCT ID: NCT05199493 Completed - Cardiac Surgery Clinical Trials

Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

AIDED
Start date: December 27, 2021
Phase: Phase 3
Study type: Interventional

The aim of this study is to evaluate whether adding angiotensin II to the standard of care is superior compared to the standard of care alone with respect to kidney damage (personalized approach) after cardiac surgery.